Treatment of canine atopic dermatitis with zafirlukast, a leukotriene-receptor antagonist: a single-blinded, placebo-controlled study.

@article{Senter2002TreatmentOC,
  title={Treatment of canine atopic dermatitis with zafirlukast, a leukotriene-receptor antagonist: a single-blinded, placebo-controlled study.},
  author={David A Senter and Danny Scott and William H. Miller},
  journal={The Canadian veterinary journal = La revue veterinaire canadienne},
  year={2002},
  volume={43 3},
  pages={203-6}
}
Zafirlukast and placebo were administered orally as individual agents to 20 dogs with atopic dermatitis. The pruritus was effectively reduced by at least 50% in 2/18 (11%) dogs that completed the trial with zafirlukast. Two dogs vomited after administration of the active drug.